Henrik Ancher-Jensen
Corporate Officer/Principal chez AGILENT TECHNOLOGIES, INC.
Fortune : 11 M $ au 30/04/2024
Postes actifs de Henrik Ancher-Jensen
Sociétés | Poste | Début | Fin |
---|---|---|---|
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/09/2012 | - |
Historique de carrière de Henrik Ancher-Jensen
Anciens postes connus de Henrik Ancher-Jensen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Directeur des opérations | 01/09/2010 | 01/09/2012 |
Directeur Technique/Scientifique/R&D | 01/01/2006 | 01/09/2010 |
Formation de Henrik Ancher-Jensen
University of Aarhus | Undergraduate Degree |
Statistiques
Internationale
Danemark | 3 |
Etats-Unis | 2 |
Opérationnelle
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
- Bourse
- Insiders
- Henrik Ancher-Jensen
- Expérience